CLICK HERE TO JOIN IBF MAILING LIST

upcoming events



 

Join us on LinkedIn Facebook

Showing record 67 of 72 | Index |

 

 

Opportunities and Challenges Facing the Israeli Biotech Industry.

 

Panelists:

 

  • Tamar Howson - Senior VP, Corporate and Business Development - Bristol Myers Squibb
  • Jeremy Levin - Global Head strategic Alliances - Novartis
  • Yael Cohen - Associate Director Clinical Research, Merck
  • James Tanenbaum - Partner with Morrison & Foerster LLP

 

The Israeli Business Forum, in cooperation with the America-Israel Chamber of Commerce, hosted a unique event targeting Life Science executives, investors, legal and accounting professionals and supporters of the Israeli Biotech Industry. The panel composed of leading executives from top pharmaceutical companies discussed the opportunities and challenges facing the Israeli Biotech industry.

 

The panel from left to right: James Tanenbaum, Jeremy Levin, Tamar Howson, Yael Cohen, Moderator Ranan Lachman.